Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study
Crossref DOI link: https://doi.org/10.1186/s12885-016-2113-8
Published Online: 2016-02-10
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stein, Alexander
Quidde, Julia
Schröder, Jan Klaus
Göhler, Thomas
Tschechne, Barbara
Valdix, Annette-Rosel
Höffkes, Heinz-Gert
Schirrmacher-Memmel, Silke
Wohlfarth, Tim
Hinke, Axel
Engelen, Andreas
Arnold, Dirk
Funding for this research was provided by:
F. Hoffman-La Roche